EyePoint Pharmaceuticals
EyePoint is a Massachusetts-based pharmaceutical company that develops and commercializes ophthalmic therapeutic products for the treatment of eye disorders.
Business Model:
Revenue: $79.4M
Employees: 51-200
Industries / Tags:
Detailed EyePoint Pharmaceuticals Information
Geographic Data
Address: 480 Pleasant Street
City: Watertown
State: MA
Zip: 02472
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$45M
Raised Total:$438M
Social
Metrics
1,911,507Website Global Rank
11,310Website Monthly Traffic
Twitter Followers
Description
EyePoint is a Massachusetts-based pharmaceutical company that develops and commercializes ophthalmic therapeutic products for the treatment of eye disorders.
Contact Phone:
+18333937646
Contact Email:
EyePoint Pharmaceuticals went public on 2/4/2005 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/4/2005
Ticker Symbol:
EYPT
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2013 | Post-IPO Equity | $10.8M | 3/2014 | Post-IPO Equity | 1 | $7M |
RA Capital Management RA Capital Management |
11/2021 | Post-IPO Equity | $115.4M | 1/2021 | Post-IPO Equity | $0 |
Ocumension Therapeutics Ocumension Therapeutics Ocumension Therapeutics Ocumension Therapeutics |
12/2020 | Post-IPO Equity | $15.7M |
Ocumension Therapeutics |
3/2022 | Post-IPO Debt | 1 | $45M |
Silicon Valley Bank Silicon Valley Bank |
10/2018 | Post-IPO Equity | 2 | $29M |
EW Healthcare Partners Rosalind Advisors EW Healthcare Partners Rosalind Advisors EW Healthcare Partners Rosalind Advisors EW Healthcare Partners Rosalind Advisors |
7/2012 | Post-IPO Equity | $40M | 4/2020 | Debt | $2M |
Silicon Valley Bank |
2/2019 | Debt Financing | 1 | $60M |
CRG CRG |
2/2021 | Post-IPO Equity | $100.1M | 2/2021 | Post-IPO Equity | $115M | 1/2021 | Post-IPO Equity | 1 | $15.7M |
Ocumension Therapeutics Ocumension Therapeutics Ocumension Therapeutics Ocumension Therapeutics |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2018 | Icon Bioscience |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
